Skip to main content
Log in

Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund’s Adjuvant Peripheral Injection

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Ligustilide is a major component of Radix Angelica Sinensis and reported to have anti-inflammatory and anti-nociceptive effects. Toll-like receptor 4 (TLR4) has been shown to be expressed in the spinal cord and be involved in inflammatory pain and neuropathic pain. Whether ligustilide can inhibit spinal TLR4 expression in inflammatory pain is still unknown. In the present study, we intravenously injected ligustilide daily for 4 days, with the first injection given at 1 h before complete Freund’s adjuvant (CFA) injection. We tested the analgesic effect of ligustilide by behavioral test and checked the expression and distribution of TLR4 in the spinal cord by real-time quantitative PCR, Western blot, and immunofluorescence. Our data showed that repeated daily intravenous treatment with ligustilide alleviated CFA-induced heat hyperalgesia and mechanical allodynia. The same treatment also inhibited CFA-induced TLR4 mRNA and protein increase in the spinal cord. Immunofluorescence double staining showed that TLR4 was predominantly expressed in spinal astrocytes. In primary cultured astrocytes, ligustilide dose-dependently reduced lipopolysaccharide-induced upregulation of TLR4 mRNA expression. These data indicate that ligustilide treatment reduces TLR4 expression in spinal astrocytes and is an effective therapy for inflammatory pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

TLR4:

Toll-like receptor 4

CFA:

Complete Freund’s adjuvant

LPS:

Lipopolysaccharide

FBS:

Fetal bovine serum

DMEM:

Dulbecco’s Modified Eagle’s Medium

qPCR:

Real-time quantitative PCR

References

  • Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B (2008) Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56(12):1312–1319

    Article  PubMed  Google Scholar 

  • Cao H, Zhang YQ (2008) Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 32(5):972–983

    Article  PubMed  Google Scholar 

  • Casula M, Iyer AM, Spliet WG, Anink JJ, Steentjes K, Sta M, Troost D, Aronica E (2011) Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience 179:233–243

    Article  PubMed  CAS  Google Scholar 

  • Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441–462

    Article  PubMed  CAS  Google Scholar 

  • Du J, Yu Y, Ke Y, Wang C, Zhu L, Qian ZM (2007) Ligustilide attenuates pain behavior induced by acetic acid or formalin. J Ethnopharmacol 112(1):211–214

    Article  PubMed  CAS  Google Scholar 

  • Feng Z, Lu Y, Wu X, Zhao P, Li J, Peng B, Qian Z, Zhu L (2012) Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusion. J Ethnopharmacol 144(2):313–321

    Article  PubMed  CAS  Google Scholar 

  • Gao YJ, Ji RR (2010) Targeting astrocyte signaling for chronic pain. Neurotherapeutics 7(4):482–493

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, Park JY, Lind AL, Ma Q, Ji RR (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29(13):4096–4108

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Gao YJ, Xu ZZ, Liu YC, Wen YR, Decosterd I, Ji RR (2010) The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition. Pain 148(2):309–319

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Gosselin RD, Suter MR, Ji RR, Decosterd I (2010) Glial cells and chronic pain. Neuroscientist 16(5):519–531

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ji RR, Berta T, Nedergaard M (2013) Glia and pain: is chronic pain a gliopathy? Pain 154:S10–S28

    Article  PubMed  PubMed Central  Google Scholar 

  • Kuang X, Wang LF, Yu L, Li YJ, Wang YN, He Q, Chen C, Du JR (2014) Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic Biol Med 71:165–175

    Article  PubMed  CAS  Google Scholar 

  • Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22(7):2478–2486

    PubMed  CAS  Google Scholar 

  • Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 100(14):8514–8519

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Li Y, Zhang H, Kosturakis AK, Jawad AB, Dougherty PM (2014) Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy. J Pain 15(7):712–725

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, Booth N, Constantinou AI, Pezzuto JM, Fong HH et al (2001) Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49(5):2472–2479

    Article  PubMed  CAS  Google Scholar 

  • Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B (2013) Importance of glial activation in neuropathic pain. Eur J Pharmacol 716:106–119

    Article  PubMed  CAS  Google Scholar 

  • Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K (2008) Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 28(48):12775–12787

    Article  PubMed  CAS  Google Scholar 

  • Nakagawa T, Kaneko S (2010) Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 114(4):347–353

    Article  PubMed  CAS  Google Scholar 

  • Peng HY, Du JR, Zhang GY, Kuang X, Liu YX, Qian ZM, Wang CY (2007) Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats. Biol Pharm Bull 30(2):309–312

    Article  PubMed  CAS  Google Scholar 

  • Peng B, Zhao P, Lu YP, Chen MM, Sun H, Wu XM, Zhu L (2013) Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Brain Res 1520:168–177

    Article  PubMed  CAS  Google Scholar 

  • Ren K, Dubner R (2008) Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 21(5):570–579

    Article  PubMed  PubMed Central  Google Scholar 

  • Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, Chanda ML, Graham AC, Topham L, Beggs S et al (2011) Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci 31(43):15450–15454

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Su YW, Chiou WF, Chao SH, Lee MH, Chen CC, Tsai YC (2011) Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-kappaB and AP-1 signaling pathways. Int Immunopharmacol 11(9):1166–1172

    Article  PubMed  CAS  Google Scholar 

  • Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 102(16):5856–5861

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Vallejo R, Tilley DM, Vogel L, Benyamin R (2010) The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 10(3):167–184

    Article  PubMed  Google Scholar 

  • van Noort JM, Bsibsi M (2009) Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res 175:139–148

    Article  PubMed  Google Scholar 

  • Wang J, Du JR, Wang Y, Kuang X, Wang CY (2010) Z-ligustilide attenuates lipopolysaccharide-induced proinflammatory response via inhibiting NF-kappaB pathway in primary rat microglia. Acta Pharmacol Sin 31(7):791–797

    Article  PubMed  PubMed Central  Google Scholar 

  • Watkins LR, Hutchinson MR, Milligan ED, Maier SF (2007) “Listening” and “talking” to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev 56(1):148–169

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • White FA, Wilson NM (2008) Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol 21(5):580–585

    Article  PubMed  PubMed Central  Google Scholar 

  • Wieseler-Frank J, Maier SF, Watkins LR (2004) Glial activation and pathological pain. Neurochem Int 45(2–3):389–395

    Article  PubMed  CAS  Google Scholar 

  • Wu XM, Qian ZM, Zhu L, Du F, Yung WH, Gong Q, Ke Y (2011) Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. Br J Pharmacol 164(2):332–343

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Yim TK, Wu WK, Pak WF, Mak DH, Liang SM, Ko KM (2000) Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented ‘Dang-Gui decoction for enriching blood’, a compound formulation, ex vivo. Phytother Res 14(3):195–199

    Article  PubMed  CAS  Google Scholar 

  • Zhao LX, Jiang BC, Wu XB, Cao DL, Gao YJ (2014) Ligustilide attenuates inflammatory pain via inhibition of NFkappaB-mediated chemokines production in spinal astrocytes. Eur J Neurosci 39(8):1391–1402

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Jun Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, B., Li, F., Zhao, LX. et al. Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund’s Adjuvant Peripheral Injection. Cell Mol Neurobiol 36, 143–149 (2016). https://doi.org/10.1007/s10571-015-0228-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-015-0228-0

Keywords

Navigation